Table 3 Clinical characteristics of patients with or without high-attenuating aortic wall diagnosed based on quantitative analysis
From: Quantitative analysis of vascular signs on early postmortem multi-detector computed tomography
| Â | High- attenuating aortic wall | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Â | Early postmortem | Surviving patients | Control patients | ||||||
Clinical characteristics | (+) 34 cases* (35.4%) | (-) 62 cases (64.6%) | p value | (+) 11 cases* (23.4%) | (-) 36 cases (76.6%) | p value | (+) 10 cases** (21.3%) | (-) 37cases (78.7%) | p value |
Age (years) | 70.0 ± 17.6 (25–94) | 69.6 ± 17.1 (18–94) | 0.9360 | 62.3 ± 15.2 (34–90) | 65.5 ± 16.7 (18–98) | 0.5680 | 69.3 ± 11.6 (48–88) | 64.9 ± 17.4 (18–96) | 0.4504 |
Male/Female | 23/11 | 39/23 | 0.6421 | 6/5 | 23/13 | 0.5769 | 4/6 | 22/15 | 0.2721 |
Pectoralis major muscle thickness (mm) | 7.8 ± 3.4 (2–15) | 8.0 ± 2.3 (3–13) | 0.8065 | 8.0 ± 2.0 (5–11) | 8.4 ± 2.4 (3–13) | 0.6465 | 8. 1 ± 1.8 (6–13) | 7.7 ± 1.9 (4–13) | 0.5385 |
Presternal fat depth mm) | 4.3 ± 3.1 (1–17) | 7.8 ± 4.1 (1–19) | <0.0001 | 4.0 ± 1.8 (1–7) | 7.8 ± 6.0 (1–30) | 0.0431 | 9.0 ± 4.1 (4–15) | 7.4 ± 3.8 (2–20) | 0.2501 |
Duration time of CPR (minutes) | 46.6 ± 9.7 (30–72) | 43.1 ± 9.0 (23–79) | 0.8986 | 19.8 ± 8.1 (10–39) | 18.4 ± 7.8 (5–38) | 0.5673 | NP | NA | |
Infused volume of the Ringer’s solution(mL) | 779.7 ± 430.4 (420–1500) | 759.7 ± 316.6 (400–1980) | 0.1685 | 463.6 ± 143.4 (300–800) | 505.4 ± 16.0 (300–1200) | 0.4406 | NP | NA | |
Infused dose of Epinephrine (mg) | 5.0 ± 2.3 (0–9) | 4.1 ± 2.8 (0–9) | 0.7960 | 1.1 ± 1.2 (0–4) | 0.8 ± 1.0 (0–4) | 0.4098 | NP | NA | |
Time between stopping CPR and MDCT scanning (minutes) | 8.0 ± 1.2 (5–10) | 8.3 ± 1.1 (5–10) | 0.1138 | 8.5 ± 1.1 (7–10) | 8.6 ± 0.9 (6–10) | 0.6702 | NP | NA | |